BetterMe Rx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.5/10
Best for: an oral route if you will not self-inject
BetterMe Rx's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked July 2026
BetterMe Rx lists compounded semaglutide at $199/mo and compounded tirzepatide at $299/mo, in injectable and oral daily tablet form. It is LegitScript verified and sells in all 50 states. Six pharmacy partners are named with phone numbers, the strongest pharmacy transparency in our register.
Is BetterMe Rx legit?
Yes. BetterMe Rx is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 6.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a BetterMe Rx promo or coupon code?
BetterMe Rx has no code to type in. The current offer: Save $300 on your first weight loss order (. It applies at checkout on its own. Coupon sites advertising a "BetterMe Rx promo code" are not a source we can vouch for.
See how BetterMe Rx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to BetterMe Rx
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
BetterMe Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How BetterMe Rx scores
Six columns, each one computed from something BetterMe Rx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.5/10$199/month is 8% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
6.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves 50 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on BetterMe Rx
Last checked July 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: all 50
- Checked FDA warning letters for BetterMe Rx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with BetterMe Rx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1BetterMe Rx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask BetterMe Rx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- BetterMe Rx serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GLP-1 medications BetterMe Rx offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
3-month plan $597 sale price (regular $747 = $249/mo). Headline $199/mo is sale-dependent.
Sale-dependent: a sitewide sale applies.
3-month plan $897 sale price (regular $1,047 = $349/mo). Headline $299/mo is sale-dependent.
Sale-dependent: a sitewide sale applies.
Check the price yourself before you pay
Every figure here was read off BetterMe Rx's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to BetterMe Rx
Against it
- Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What BetterMe Rx charges
BetterMe Rx charges $199/month.
- Compounded semaglutide: $199/month
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $299/month
- Compounded tirzepatide: $299/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so BetterMe Rx's $199 lands mid-market. Price is unlikely to be the deciding factor.
RNK Health dispenses semaglutide and tirzepatide from $197/month, which makes it the fair comparison to run before you commit here.
What BetterMe Rx dispenses
BetterMe Rx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at BetterMe Rx at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
BetterMe Rx tells you that it treats patients in all 50 states. We found no FDA warning letters issued to BetterMe Rx. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If BetterMe Rx will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether BetterMe Rx bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
- you need access wherever you live
Our read
BetterMe Rx lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. HumeCare+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
BetterMe Rx's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay BetterMe Rx
Starting at $199 a month. Check today's price, then start the intake.
Where BetterMe Rx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare BetterMe Rx head to head
The sellers closest to BetterMe Rx on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this BetterMe Rx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of July 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See BetterMe Rx's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.